Literature DB >> 9350744

Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups.

J H Helbig1, J B Kurtz, M C Pastoris, C Pelaz, P C Lück.   

Abstract

Legionella pneumophila accounts for the majority of cases of Legionnaires' disease. By using rabbit antisera, the species has been divided into 14 numbered and 1 unnumbered serogroups. To recognize the antigenic diversity of the lipopolysaccharide (LPS) responsible for this classification, the Dresden Legionella LPS MAb panel, containing 98 monoclonal antibodies (MAbs), was created. Each serogroup reference strain possesses at least one specific epitope not found on any other reference strain and therefore designated the serogroup-specific epitope. When the appropriate MAbs were used for serotyping of 1,064 human and environmental isolates, 1,045 (98%) could be placed into the known serogroups. In most cases (97%), this was in agreement with the polyclonal typing. Of the 29 isolates that showed strong cross-reactivities with the rabbit antiserum panel, 11 could be typed easily by MAbs; for the remaining 18, however, only serogroup-cross-reactive epitopes could be determined. Below the serogroup level, monoclonal subtypes were found for 11 serogroups. Altogether, the Dresden Legionella LPS MAb panel was able to divide the 1,064 isolates tested into 64 phenons, indicating its usefulness for both serogrouping and subgrouping of L. pneumophila strains. In order to compare the identities of patient and environmental isolates, testing their reactivity with MAbs should be the first step, especially if large numbers of colonies are to be typed. Only in cases of identical patterns are the more time consuming and expensive genetic fingerprints necessary. Moreover, the MAbs can also be used for specific antigen detection in respiratory specimens on the serogroup or subgroup level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350744      PMCID: PMC230072          DOI: 10.1128/jcm.35.11.2841-2845.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Taxonomic investigation of Legionella pneumophila using monoclonal antibodies.

Authors:  R J Brindle; T N Bryant; P W Draper
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

2.  Serotyping, ribotyping, PCR-mediated ribosomal 16S-23S spacer analysis and arbitrarily primed PCR for epidemiological studies on Legionella pneumophila.

Authors:  A Van Belkum; H Maas; H Verbrugh; N Van Leeuwen
Journal:  Res Microbiol       Date:  1996-06       Impact factor: 3.992

3.  Simple immunization protocol for high frequency production of soluble antigen-specific hybridomas.

Authors:  M Cianfriglia; D Armellini; A Massone; M Mariani
Journal:  Hybridoma       Date:  1983

4.  Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness.

Authors:  A L Reingold; B M Thomason; B J Brake; L Thacker; H W Wilkinson; J N Kuritsky
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

5.  Legionella pneumophila serogroup Lansing 3 isolated from a patient with fatal pneumonia, and descriptions of L. pneumophila subsp. pneumophila subsp. nov., L. pneumophila subsp. fraseri subsp. nov., and L. pneumophila subsp. pascullei subsp. nov.

Authors:  D J Brenner; A G Steigerwalt; P Epple; W F Bibb; R M McKinney; R W Starnes; J M Colville; R K Selander; P H Edelstein; C W Moss
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Serogroup specificity of Legionella pneumophila is related to lipopolysaccharide characteristics.

Authors:  C A Ciesielski; M J Blaser; W L Wang
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

7.  Monoclonal antibodies to enterobacterial common antigen and to Escherichia coli lipopolysaccharide outer core: demonstration of an antigenic determinant shared by enterobacterial common antigen and E. coli K5 capsular polysaccharide.

Authors:  H Peters; M Jürs; B Jann; K Jann; K N Timmis; D Bitter-Suermann
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies.

Authors:  J R Joly; R M McKinney; J O Tobin; W F Bibb; I D Watkins; D Ramsay
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

9.  Legionella waltersii sp. nov. and an unnamed Legionella genomospecies isolated from water in Australia.

Authors:  R F Benson; W L Thacker; M I Daneshvar; D J Brenner
Journal:  Int J Syst Bacteriol       Date:  1996-07

10.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

  10 in total
  44 in total

1.  Multiple types of Legionella pneumophila serogroup 6 in a hospital heated-water system associated with sporadic infections.

Authors:  P Visca; P Goldoni; P C Lück; J H Helbig; L Cattani; G Giltri; S Bramati; M Castellani Pastoris
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Molecular cloning and characterization of a locus responsible for O acetylation of the O polysaccharide of Legionella pneumophila serogroup 1 lipopolysaccharide.

Authors:  C H Zou; Y A Knirel; J H Helbig; U Zähringer; C S Mintz
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

3.  Contribution of amoebic coculture to recovery of Legionella isolates from respiratory samples: prospective analysis over a period of 32 months.

Authors:  G Descours; A Suet; C Ginevra; C Campese; S Slimani; F Ader; D Che; G Lina; S Jarraud
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

4.  Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires' disease.

Authors:  M Mentasti; N K Fry; B Afshar; C Palepou-Foxley; F C Naik; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

5.  Evaluation of the Duopath Legionella lateral flow assay for identification of Legionella pneumophila and Legionella species culture isolates.

Authors:  Jürgen Herbert Helbig; Paul Christian Lück; Britta Kunz; Andreas Bubert
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

6.  Seroepidemiological study after a long-distance industrial outbreak of legionnaires' disease.

Authors:  E Wedege; T Bergdal; K Bolstad; D A Caugant; J Efskind; H E Heier; A Kanestrøm; B H Strand; I S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

7.  A hospital-associated outbreak of Legionnaires' disease caused by Legionella pneumophila serogroup 1 is characterized by stable genetic fingerprinting but variable monoclonal antibody patterns.

Authors:  Sverker Bernander; Kerstin Jacobson; Jürgen Herbert Helbig; Paul Christian Lück; Monica Lundholm
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

8.  Sequence-based typing of Legionella pneumophila serogroup 1 offers the potential for true portability in legionellosis outbreak investigation.

Authors:  Valeria Gaia; Norman K Fry; Timothy G Harrison; Raffaele Peduzzi
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease.

Authors:  Jürgen H Helbig; Søren A Uldum; Sverker Bernander; Paul Christian Lück; Günther Wewalka; Bill Abraham; Valeria Gaia; Timothy G Harrison
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples.

Authors:  J A Domínguez; N Galí; P Pedroso; A Fargas; E Padilla; J M Manterola; L Matas
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.